LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway

Prostate cancer (PCa) is the most commonly diagnosed malignancy in male. Numerous studies have focused on the molecular mechanisms of carcinogenesis and progression, aiming at developing new therapeutic strategies. Here we describe Lanthionine synthase C-like protein 1 (LanCL1), a member of the LanC...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jianqing, Xiao, Qianyi, Chen, Xu, Tong, Shijun, Sun, Jianliang, Lv, Ruitu, Wang, Siqing, Gou, Yuancheng, Tan, Li, Xu, Jianfeng, Fan, Caibin, Ding, Guanxiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833716/
https://www.ncbi.nlm.nih.gov/pubmed/29416001
http://dx.doi.org/10.1038/s41419-017-0207-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833716/
https://www.ncbi.nlm.nih.gov/pubmed/29416001
http://dx.doi.org/10.1038/s41419-017-0207-0

Ejemplares similares